Correlation Between OMX Stockholm and Prostatype Genomics

Can any of the company-specific risk be diversified away by investing in both OMX Stockholm and Prostatype Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OMX Stockholm and Prostatype Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OMX Stockholm Mid and Prostatype Genomics AB, you can compare the effects of market volatilities on OMX Stockholm and Prostatype Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OMX Stockholm with a short position of Prostatype Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OMX Stockholm and Prostatype Genomics.

Diversification Opportunities for OMX Stockholm and Prostatype Genomics

-0.77

Correlation Coefficient

OMX Stockholm  Prostatype Genomics

Pay attention - limited upside

The 3 months correlation between OMX and Prostatype is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding OMX Stockholm Mid and Prostatype Genomics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prostatype Genomics and OMX Stockholm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OMX Stockholm Mid are associated (or correlated) with Prostatype Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prostatype Genomics has no effect on the direction of OMX Stockholm i.e., OMX Stockholm and Prostatype Genomics go up and down completely randomly.

Pair Corralation between OMX Stockholm and Prostatype Genomics

Assuming the 90 days trading horizon OMX Stockholm Mid is expected to generate 0.06 times more return on investment than Prostatype Genomics. However, OMX Stockholm Mid is 17.53 times less risky than Prostatype Genomics. It trades about 0.22 of its potential returns per unit of risk. Prostatype Genomics AB is currently generating about -0.04 per unit of risk. If you would invest  169,265  in OMX Stockholm Mid on April 23, 2025 and sell it today you would earn a total of  5,392  from holding OMX Stockholm Mid or generate 3.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

OMX Stockholm Mid  vs.  Prostatype Genomics AB

Pair Trading with OMX Stockholm and Prostatype Genomics

The main advantage of trading using opposite OMX Stockholm and Prostatype Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OMX Stockholm position performs unexpectedly, Prostatype Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prostatype Genomics will offset losses from the drop in Prostatype Genomics' long position.

The idea behind OMX Stockholm Mid and Prostatype Genomics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.